Genes encoding proteoglycans are associated with the risk of anterior cruciate ligament ruptures

British Journal of Sports Medicine

Volumn 48, Issue 22, 2014, Pages 1640-1646

  Mannion, Sasha ^a,b   Mtintsilana, Asanda ^a   Posthumus, Michael ^a,c   Van Der Merwe, Willem ^c   Hobbs, Hayden ^c   Collins, Malcolm ^a,d   September, Alison V ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c Sports Science Orthopaedic Clinic   (South Africa)

^d SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACAN PROTEIN, HUMAN; AGGRECAN; BGN PROTEIN, HUMAN; BIGLYCAN; DCN PROTEIN, HUMAN; DECORIN; FIBRILLAR COLLAGEN; FIBROMODULIN; KERATAN SULFATE; LUMICAN; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN; SCLEROPROTEIN;

ADULT; ANTERIOR CRUCIATE LIGAMENT; CASE CONTROL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HAPLOTYPE; HUMAN; INJURIES; MALE; RISK FACTOR; RUPTURE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGGRECANS; ANTERIOR CRUCIATE LIGAMENT; BIGLYCAN; CASE-CONTROL STUDIES; CHONDROITIN SULFATE PROTEOGLYCANS; DECORIN; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBRILLAR COLLAGENS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; KERATAN SULFATE; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEOGLYCANS; RISK FACTORS; RUPTURE;

EID: 84908429359     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsports-2013-093201     Document Type: Article

References (61)

1. Harner CD, Paulos LE, Greenwald AE, et al. Detailed analysis of patients with bilateral anterior cruciate ligament injuries. Am J Sports Med 1994;22:37-43.
2. Flynn RK, Pedersen CL, Birmingham TB, et al. The familial predisposition toward tearing the anterior cruciate ligament: a case control study. Am J Sports Med 2005;33:23-8.
3. Khoschnau S, Melhus H, Jacobson A, et al. Type I collagen alpha1 Sp1 polymorphism and the risk of cruciate ligament ruptures or shoulder dislocations. Am J Sports Med 2008;36:2432-6.
4. Posthumus M, September AV, O'Cuinneagain D, et al. The COL5A1 gene is associated with increased risk of anterior cruciate ligament ruptures in female participants. Am J Sports Med 2009;37:2234-40.
5. Posthumus M, September AV, Keegan M, et al. Genetic risk factors for anterior cruciate ligament ruptures: COL1A1 gene variant. Br J Sports Med 2009;43:352-6.
6. Posthumus M, September AV, O'Cuinneagain D, et al. The association between the COL12A1 gene and anterior cruciate ligament ruptures. Br J Sports Med 2010;44:1160-5.
7. Posthumus M, Collins M, van der Merwe L, et al. Matrix metalloproteinase genes on chromosome 11q22 and the risk of anterior cruciate ligament (ACL) rupture. Scand J Med Sci Sports 2012;22:523-33.
8. Chen S, Birk DE. The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly. FEBS J 2013;280:2120-37.
9. Stattin E, Wiklund F, Lindblom K, et al. A missense mutation in the aggrecan C-type lectin domain disrupts extracellular matrix interactions and causes dominant familial osteochondritis dissecans. Am J Hum Genet 2010;86:126-37.
10. Tompson SW, Merriman B, Funari VA, et al. A recessive skeletal dysplasia, SEMD aggrecan type, results from a missense mutation affecting the C-type lectin domain of aggrecan. Am J Hum Genet 2009;84:72-9.
11. Corsi A, Xu T, Chen XD, et al. Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J Bone Miner Res 2002;17:1180-9.
12. Ameye L, Young MF. Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 2002;12:107R-16R.
13. Danielson KG, Baribault H, Holmes DF, et al. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997;136:729-43.
14. Young K, Samiric T, Feller J, et al. Extracellular matrix content of ruptured anterior cruciate ligament tissue. Knee 2011;18:242-6.
15. Weedon MN, Lango H, Lindgren CM, et al. Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet 2008;40:575-83.
16. Videman T, Saarela J, Kaprio J, et al. Associations of 25 structural, degradative, and inflammatory candidate genes with lumbar disc desiccation, bulging, and height narrowing. Arthritis Rheum 2009;60:470-81.
17. N'Diaye A, Chen GK, Palmer CD, et al. Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry. PLoS Genet 2011;7:e1002298.
18. Yip SP, Leung KH, Ng PW, et al. Evaluation of proteoglycan gene polymorphisms as risk factors in the genetic susceptibility to high myopia. Invest Ophthalmol Vis Sci 2011;52:6396-403.
19. Chen ZT, Wang IJ, Shih Y, et al. The association of haplotype at the lumican gene with high myopia susceptibility in Taiwanese patients. Ophthalmology 2009;116:1920-7.
20. Zhang F, Zhu T, Zhou Z, et al. Association of lumican gene with susceptibility to pathological myopia in the northern han ethnic chinese. J Ophthalmol 2009;2009:514306.
21. Little J, Higgins JPT, Ioannidis JPA, et al. Strengthening the reporting of genetic association studies (STREGA)-an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol 2009;62:597-608.e4.
22. Marshall S, Padua D, McGrath M. Incidence of ACL injuries. In: Hewett T, Schultz S, Griffin L. eds. Understanding and preventing noncontact ACL injuries. Champaign, IL: Human Kinetics, 2007:5-30.
23. Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991;19:5444.
24. Mokone GG, Gajjar M, September AV, et al. The guanine-thymine dinucleotide repeat polymorphism within the tenascin-C gene is associated with Achilles tendon injuries. Am J Sports Med 2005;33:1016-21.
25. van Diemen CC, Postma DS, Vonk JM, et al. Decorin and TGF-beta1 polymorphisms and development of COPD in a general population. Respir Res 2006;7:89.
26. Kelemen LE, Couch FJ, Ahmed S, et al. Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies. Breast Cancer Res 2008;10:R98.
27. Peat RA, Gécz J, Fallon JR, et al. Exclusion of biglycan mutations in a cohort of patients with neuromuscular disorders. Neuromuscul Disord 2008;18:606-9.
28. Dimasi DP, Burdon KP, Hewitt AW, et al. Candidate gene study to investigate the genetic determinants of normal variation in central corneal thickness. Mol Vis 2010;16:562-9.
29. Couch FJ, Wang X, McWilliams RR, et al. Association of breast cancer susceptibility variants with risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2009;18:3044-8.
30. Gaunt T, Rodríguez S, Day I. Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool 'CubeX'. BMC Bioinformatics 2007;8:428.
31. Chiu R, Li W, Herber RP, et al. Effects of biglycan on physico-chemical properties of ligament-mineralized tissue attachment sites. Arch Oral Biol 2012;57:177-87.
32. Kresse H, Schonherr E. Proteoglycans of the extracellular matrix and growth control. J Cell Physiol 2001;189:266-74.
33. Scott JE. Proteoglycan-fibrillar collagen interactions. Biochem J 1988;252:313-23.
34. Heinegard D. Proteoglycans and more-from molecules to biology. Int J Exp Pathol 2009;90:575-86.
35. Heinegard D, Hascall VC. Aggregation of cartilage proteoglycans. 3. Characteristics of the proteins isolated from trypsin digests of aggregates. J Biol Chem 1974;249:4250-6.
36. Kiani C, Chen L, Lee V, et al. Identification of the motifs and amino acids in aggrecan G1 and G2 domains involved in product secretion. Biochemistry 2003;42:7226-37.
37. Aspberg A, Adam S, Kostka G, et al. Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. J Biol Chem 1999;274:20444-9.
38. Bredrup C, Knappskog PM, Majewski J, et al. Congenital stromal dystrophy of the cornea caused by a mutation in the decorin gene. Invest Ophthalmol Vis Sci 2005;46:420-6.
39. Rodahl E, Van Ginderdeuren R, Knappskog PM, et al. A second decorin frame shift mutation in a family with congenital stromal corneal dystrophy. Am J Ophthalmol 2006;142:520-1.
40. Reed CC, Iozzo RV. The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj J 2002;19:249-55.
41. Jepsen KJ, Wu F, Peragallo JH, et al. A syndrome of joint laxity and impaired tendon integrity in lumican- and fibromodulin-deficient mice. J Biol Chem 2002;277:35532-40.
42. Iozzo RV. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol 1997;32:141-74.
43. Schaefer L, Schaefer RM. Proteoglycans: from structural compounds to signaling molecules. Cell Tissue Res 2010;339:237-46.
44. Anderson AF, Dome DC, Gautam S, et al. Correlation of anthropometric measurements, strength, anterior cruciate ligament size, and intercondylar notch characteristics to sex differences in anterior cruciate ligament tear rates. Am J Sports Med 2001;29:58-66.
45. Raspanti M, Viola M, Forlino A, et al. Glycosaminoglycans show a specific periodic interaction with type I collagen fibrils. J Struct Biol 2008;164:134-9.
46. Tenorio DM, Santos MF, Zorn TM. Distribution of biglycan and decorin in rat dental tissue. Braz J Med Biol Res 2003;36:1061-5.
47. Hildebrand A, Romaris M, Rasmussen LM, et al. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 1994;302(Pt 2):527-34.
48. Geerkens C, Vetter U, Just W, et al. The X-chromosomal human biglycan gene BGN is subject to X inactivation but is transcribed like an X-Y homologous gene. Hum Genet 1995;96:44-52.
49. Salgado RM, Favaro RR, Martin SS, et al. The estrous cycle modulates small leucine-rich proteoglycans expression in mouse uterine tissues. Anat Rec (Hoboken) 2009;292:138-53.
50. Hong SH, Nah HY, Lee JY, et al. Analysis of estrogen-regulated genes in mouse uterus using cDNA microarray and laser capture microdissection. J Endocrinol 2004;181:157-67.
51. Liu SH, al-Shaikh R, Panossian V, et al. Primary immunolocalization of estrogen and progesterone target cells in the human anterior cruciate ligament. J Orthop Res 1996;14:526-33.
52. Silvers HJ, Mandelbaum BR. Prevention of anterior cruciate ligament injury in the female athlete. Br J Sports Med 2007;41(Suppl 1):i52-9.
53. Rodrigo MC, Martin DS, Eyster KM. Estrogen decreases biglycan mRNA expression in resistance blood vessels. Am J Physiol Regul Integr Comp Physiol 2003;285: R754-61.
54. Salgado RM, Favaro RR, Zorn TM. Modulation of small leucine-rich proteoglycans (SLRPs) expression in the mouse uterus by estradiol and progesterone. Reprod Biol Endocrinol 2011;9:22.
55. Markiewicz M, Znoyko S, Stawski L, et al. A role for estrogen receptor-alpha and estrogen receptor-beta in collagen biosynthesis in mouse skin. J Invest Dermatol 2013;133:120-7.
56. Pettersson FH, Anderson CA, Clarke GM, et al. Marker selection for genetic case-control association studies. Nat Protoc 2009;4:743-52.
57. Collins M, Posthumus M. Type V collagen genotype and exercise-related phenotype relationships: a novel hypothesis. Exerc Sport Sci Rev 2011;39:191-8.
58. Hay M, Patricios J, Collins R, et al. Association of type XI collagen genes with chronic Achilles tendinopathy in independent populations from South Africa and Australia. Br J Sports Med 2013;47:569-74.
59. Frey H, Schroeder N, Manon-Jensen T, et al. Biological interplay between proteoglycans and their innate immune receptors in inflammation. FEBS J 2013;280:2165-79.
60. Griffin LY, Albohm MJ, Arendt EA, et al. Understanding and preventing noncontact anterior cruciate ligament injuries: a review of the Hunt Valley II meeting, January 2005. Am J Sports Med 2006;34:1512-32.
61. Posthumus M, Collins M, September AV, et al. The intrinsic risk factors for ACL ruptures: an evidence-based review. Phys Sportsmed 2011;39:62-73.